Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.

Kennedy Institute building
The new floor will enable the Institute to expand its data science and clinical trials programmes

Housing more than 25 research groups, the Kennedy Institute of Rheumatology is at the forefront of research in the areas of immunity and microbiome, inflammation biology, and tissue remodelling and regeneration. Approximately 200 researchers, support staff and students work towards making fundamental discoveries about biological processes that help in the understanding of inflammatory and degenerative diseases such as rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and cancer.

A strategic objective of the Institute is to accelerate understanding of these diseases through the application of data science-based approaches complementing its long-established lab-based research. The Institute has invested substantially in this area, building a core of expertise and technologies encompassing single cell genomics, statistical genetics, microbial genomics, computational biology and clinical trials.

The full story is available on the Nuffield Department of Orthopaedics,Rheumatology & Musculoskeletal Sciences website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.